{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:51:51Z","timestamp":1790070711873,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijpharm.2017.09.037","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T18:16:52Z","timestamp":1505758612000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Preparation and investigation of P28GST-loaded PLGA microparticles for immunomodulation of experimental colitis"],"prefix":"10.1016","volume":"533","author":[{"given":"T.H. Hoang","family":"Thi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Priemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Karrout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Driss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Delbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dendooven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Flament","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Capron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Siepmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.09.037_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jddst.2015.07.022","article-title":"\u03b2-Cyclodextrin hinders PLGA plasticization during microparticle manufacturing","volume":"30","author":"Albertini","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0010","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1128\/IAI.67.5.2643-2648.1999","article-title":"Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen","volume":"67","author":"Baras","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0015","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0264-410X(99)00427-2","article-title":"Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers","volume":"18","author":"Baras","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0020","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1018822002353","article-title":"pH and osmotic pressure inside biodegradable microspheres during erosion","volume":"16","author":"Brunner","year":"1999","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.09.037_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pt.2005.01.003","article-title":"Schistosomes: the road from host-parasite interactions to vaccines in clinical trials","volume":"21","author":"Capron","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2017.03.031","article-title":"Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres","volume":"256","author":"Doty","year":"2017","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0035","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/mi.2015.62","article-title":"The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils","volume":"9","author":"Driss","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2015.06.039","article-title":"Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies","volume":"213","author":"Gasmi","year":"2015","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jddst.2015.10.009","article-title":"Importance of PLGA microparticle swelling for the control of prilocaine release","volume":"30","author":"Gasmi","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2016.08.032","article-title":"Towards a better understanding of the different release phases from PLGA microparticles: dexamethasone-loaded systems","volume":"514","author":"Gasmi","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2016.03.011","article-title":"Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere\/PVA hydrogel composites","volume":"228","author":"Gu","year":"2016","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0065","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines-current status, problems and future-prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0070","series-title":"Vaccine Design: The Subunit and Adjuvant Approach","first-page":"229","article-title":"Adjuvant properties of aluminium and calcium compounds","author":"Gupta","year":"1995"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jconrel.2016.08.023","article-title":"Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation","volume":"244","author":"Hirota","year":"2016","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2015.02.025","article-title":"Self-healing of pores in PLGAs","volume":"206","author":"Huang","year":"2015","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0085","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0264-410X(96)00048-5","article-title":"Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase","volume":"14","author":"Ivanoff","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jiang","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0095","doi-asserted-by":"crossref","first-page":"10084","DOI":"10.1021\/bi034449r","article-title":"Crystal structure of the 28kDa glutathione S-transferase from Schistosoma haematobium","volume":"42","author":"Johnson","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1021\/mp060041n","article-title":"Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins","volume":"4","author":"Kang","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2005.07.031","article-title":"How porosity and size affect the drug release mechanisms from PLGA-based microparticles","volume":"314","author":"Klose","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2004.07.029","article-title":"Mapping neutral microclimate pH in PLGA microspheres","volume":"101","author":"Li","year":"2005","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0169-409X(98)00012-X","article-title":"Poly(lactide-coglycolide) microparticles for the development of single-dose controlled-release vaccines","volume":"32","author":"O\u2019Hagan","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0120","doi-asserted-by":"crossref","first-page":"e1704","DOI":"10.1371\/journal.pntd.0001704","article-title":"Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis","volume":"6","author":"Riveau","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2015.11.008","article-title":"Acylation of arginine in goserelin-loaded PLGA microspheres","volume":"99","author":"Shirangi","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0169-409X(01)00116-8","article-title":"Mathematical modeling of bioerodible, polymeric drug delivery systems","volume":"48","author":"Siepmann","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0135","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2008.09.004","article-title":"Mathematical modeling of drug delivery","volume":"364","author":"Siepmann","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2011.10.006","article-title":"Modeling of diffusion controlled drug delivery","volume":"161","author":"Siepmann","year":"2012","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.04.044","article-title":"Mathematical modeling of drug dissolution","volume":"453","author":"Siepmann","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0150","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/bm050228k","article-title":"How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment","volume":"6","author":"Siepmann","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2017.05.001","article-title":"Limited drug solubility can be decisive even for freely soluble drugs in highly swollen matrix tablets","volume":"526","author":"Siepmann","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"article 453","key":"10.1016\/j.ijpharm.2017.09.037_bib0160","first-page":"1","article-title":"Helminth immunomodulation in autoimmune disease","volume":"8","author":"Smallwood","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","article-title":"The immunology of mucosal models of inflammation","volume":"20","author":"Strober","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.addr.2004.09.002","article-title":"Formulation aspects of biodegradable polymeric microspheres for antigen delivery","volume":"57","author":"Tamber","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0175","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s13071-016-1799-4","article-title":"Schistosomiasis vaccines: where do we stand?","volume":"9","author":"Tebeje","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0016-5085(89)90760-9","article-title":"Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease","volume":"96","author":"Wallace","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0185","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1473-3099(14)70771-6","article-title":"Helminth therapy or elimination: epidemiological, immunological, and clinical considerations","volume":"14","author":"Wammes","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpharm.2017.09.037_bib0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ibd.20633","article-title":"Helminths and the IBD hygiene hypothesis","volume":"15","author":"Weinstock","year":"2009","journal-title":"Inflamm. Bowe Dis."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317309031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317309031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T17:30:58Z","timestamp":1602955858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317309031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0378517317309031"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.037","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and investigation of P28GST-loaded PLGA microparticles for immunomodulation of experimental colitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}